Gilead to Boost Stake in Belgian Biotech Galapagos as Part of $5.1 Billion Deal - The Wall Street Journal
Gilead to Boost Stake in Belgian Biotech Galapagos as Part of $5.1 Billion Deal The Wall Street Journal
from Top stories - Google News July 15, 2019 at 01:22AM
Gilead Sciences will pay $5.1 billion to lift its stake in Galapagos NV and gain rights outside Europe to the Belgian biotechnology company's treatments in ...
View full coverage on Google Newsfrom Top stories - Google News July 15, 2019 at 01:22AM
Comments
Post a Comment